Avalo Therapeutics Inc. (AVTX) SEC News Jan. 08, 2026, 21:02 UTC New Form S-3 - Avalo Therapeutics, Inc. Filed: 2026-01-08 AccNo: 0001104659-26-002118 Size: 1 MB Full text
There are no comments here yet...